These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 25728322)

  • 1. Pertussis in infants under one year old: risk markers and vaccination status--a case-control study.
    Zamir CS; Dahan DB; Shoob H
    Vaccine; 2015 Apr; 33(17):2073-8. PubMed ID: 25728322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.
    Misegades LK; Winter K; Harriman K; Talarico J; Messonnier NE; Clark TA; Martin SW
    JAMA; 2012 Nov; 308(20):2126-32. PubMed ID: 23188029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
    Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of protection after first dose of acellular pertussis vaccine in infants.
    Quinn HE; Snelling TL; Macartney KK; McIntyre PB
    Pediatrics; 2014 Mar; 133(3):e513-9. PubMed ID: 24515514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Diphtheria-Tetanus-Acellular Pertussis Vaccine Timeliness and Number of Doses With Age-Specific Pertussis Risk in Infants and Young Children.
    Rane MS; Rohani P; Halloran ME
    JAMA Netw Open; 2021 Aug; 4(8):e2119118. PubMed ID: 34374773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age.
    Glanz JM; Narwaney KJ; Newcomer SR; Daley MF; Hambidge SJ; Rowhani-Rahbar A; Lee GM; Nelson JC; Naleway AL; Nordin JD; Lugg MM; Weintraub ES
    JAMA Pediatr; 2013 Nov; 167(11):1060-4. PubMed ID: 24019039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of pertussis vaccine effectiveness in United States air force pediatric dependents.
    Wolff G; Bell M; Escobar J; Ruiz S
    Vaccine; 2015 Jun; 33(28):3228-33. PubMed ID: 25957071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Dylag AM; Shah SI
    Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine.
    Sala-Farré MR; Arias-Varela C; Recasens-Recasens A; Simó-Sanahuja M; Muñoz-Almagro C; Pérez-Jové J
    Enferm Infecc Microbiol Clin; 2015 Jan; 33(1):27-31. PubMed ID: 24216286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age at pertussis immunization as it relates to current epidemiology and disease control.
    Funkhouser AW; Wassilak SG; Hinman AR; Orenstein WA; Mortimer EA
    Tokai J Exp Clin Med; 1988; 13 Suppl():111-5. PubMed ID: 3273610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].
    Campins M; Moreno-Pérez D; Gil-de Miguel A; González-Romo F; Moraga-Llop FA; Arístegui-Fernández J; Goncé-Mellgren A; Bayas JM; Salleras-Sanmartí L
    Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):240-53. PubMed ID: 23411362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population.
    Batra JS; Eriksen EM; Zangwill KM; Lee M; Marcy SM; Ward JI;
    Pediatrics; 2009 Mar; 123(3):951-8. PubMed ID: 19255025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential impact of acceleration of the pertussis vaccine primary series for infants.
    Shinall MC; Peters TR; Zhu Y; Chen Q; Poehling KA
    Pediatrics; 2008 Nov; 122(5):1021-6. PubMed ID: 18977982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis.
    Baxter R; Bartlett J; Fireman B; Lewis E; Klein NP
    Pediatrics; 2017 May; 139(5):. PubMed ID: 28557752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.